Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Breitmeyer

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Pharmaceutics|April 23, 2022
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer CellsDongli Liu, Gunnar F Kaufmann, James B Breitmeyer, et al.
Pain Practice : the Official Journal of World Institute of Pain|October 20, 2011
Intravenous acetaminophen for pain after major orthopedic surgery: an expanded analysisRaymond S Sinatra, Jonathan S Jahr, Lowell Reynolds, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1988
Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activitiesM L Blue, D A Hafler, J F Daley, et al.
Clinical Therapeutics|March 1, 2011
A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgerySteven J Wininger, Howard Miller, Harold S Minkowitz, et al.
Annals of Internal Medicine|December 1, 1996
Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study GroupM Schambelan, K Mulligan, C Grunfeld, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
Blood|July 11, 2006
Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximabJulie A Bowles, Siao-Yi Wang, Brian K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Breast Cancer Research : BCR|March 14, 2024
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancerRebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
Breast Cancer Research : BCR|February 26, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancerRebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Pharmaceutics|April 23, 2022
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer CellsDongli Liu, Gunnar F Kaufmann, James B Breitmeyer, et al.
Pain Practice : the Official Journal of World Institute of Pain|October 20, 2011
Intravenous acetaminophen for pain after major orthopedic surgery: an expanded analysisRaymond S Sinatra, Jonathan S Jahr, Lowell Reynolds, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1988
Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activitiesM L Blue, D A Hafler, J F Daley, et al.
Clinical Therapeutics|March 1, 2011
A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgerySteven J Wininger, Howard Miller, Harold S Minkowitz, et al.
Annals of Internal Medicine|December 1, 1996
Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study GroupM Schambelan, K Mulligan, C Grunfeld, et al.
Cancer|May 1, 1990
Adjuvant systemic therapy for patients with node-negative tumorsI C Henderson, D F Hayes, L M Parker, et al.
Blood|July 11, 2006
Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximabJulie A Bowles, Siao-Yi Wang, Brian K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Breast Cancer Research : BCR|March 14, 2024
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancerRebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
Breast Cancer Research : BCR|February 26, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancerRebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.
Pageof 4